Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Mark Stacy »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Mark R. Cookson < Mark Stacy < Marsden  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 2.
Ident.Authors (with country if any)Title
000087 (2013) Fabrizio Stocchi [Italie] ; Olivier Rascol ; Alain Destée [France] ; Nobutaka Hattori ; Robert A. Hauser ; Anthony E. Lang ; Werner Poewe [Autriche] ; Mark Stacy ; Eduardo Tolosa ; Haitao Gao ; Jennifer Nagel ; Martin Merschhemke ; Ana Graf ; Christopher Kenney ; Claudia TrenkwalderAFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
000141 (2011) Angelo Antonini [Italie] ; Pablo Martinez-Martin [Espagne] ; Ray K. Chaudhuri [Royaume-Uni] ; Marcelo Merello [Argentine] ; Robert Hauser [États-Unis] ; Regina Katzenschlager [Autriche] ; Per Odin [Allemagne] ; Mark Stacy [États-Unis] ; Fabrizio Stocchi [Italie] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Anette Schrag [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis]Wearing‐off scales in Parkinson's disease: Critique and recommendations

List of associated KwdEn.i

Nombre de
documents
Descripteur
2Antiparkinson Agents (adverse effects)
2Humans
2Parkinson Disease (drug therapy)
2Severity of Illness Index
1Aged
1Antiparkinson Agents (therapeutic use)
1Cognition Disorders (drug therapy)
1Cognition Disorders (etiology)
1Dopamine Agents (adverse effects)
1Dose-Response Relationship, Drug
1Double-Blind Method
1Dyskinesia, Drug-Induced (drug therapy)
1Dyskinesia, Drug-Induced (etiology)
1Female
1Follow-Up Studies
1Indoles (therapeutic use)
1International Cooperation
1Levodopa (adverse effects)
1Male
1Middle Aged
1Nervous system diseases
1Outcome Assessment (Health Care)
1Parkinson Disease (complications)
1Parkinson Disease (diagnosis)
1Parkinson Disease (physiopathology)
1Parkinson disease
1Parkinson's disease
1Psychiatric Status Rating Scales
1Psychometrics
1Questionnaires (standards)
1Recommendation
1Reliability
1Time Factors
1Validity
1Weights and Measures (standards)
1clinimetrics
1psychometrics
1rating scales
1reliability
1validity
1wearing‐off

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Mark Stacy" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Mark Stacy" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Mark Stacy
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024